Migraine and Headache

Latest

Lasmiditan Increases Odds of Freedom From Migraine Attacks

By

Nicole Clemons

Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.

Fremanezumab Reduces Migraine Days in Migraine With Comorbid Depression

By

Jessica Nye, PhD

A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.

Effects of Migraine on Pregnancy Planning in Women

Migraine has a considerable impact on women’s pregnancy plans, with about 20% avoiding pregnancy due to migraine.

Incidence of Migraine Headache in Multiple Sclerosis

Internationally, more than 3 in 10 patients with multiple sclerosis with migraine.

Early Pain Freedom With Lasmiditan, Ubrogepant, and Rimegepant

By

Amit Akirov, MD

The therapeutic gain for 2-hour pain freedom is an important outcome to assess efficacy of acute migraine therapies.

Occipital Headaches More Frequent Among Those With Vestibular Migraine

By

Jessica Nye, PhD

Patients with vestibular migraine are more likely to have occipital headaches than those without vestibular symptoms.

Occipital Headache More Common in Those With Vestibular Migraine

By

Brandon May

Compared to patients with migraine without vestibular symptoms, those with vestibular migraine are more likely to experience occipital headaches.

Heterogeneous Headache Characteristics Associated With COVID-19

By

Rose Reeb

The heterogeneous expression of headache associated with COVID-19 indicates various underlying pathophysiological mechanisms.

Atogepant Reduces Monthly Migraine Days in Phase 3 Prevention Trial

By

Brian Park, PharmD

The ADVANCE study included 910 adults who experienced 4 to 14 migraines per month.

Lasmiditan Efficacy Similar Across Multiple Patient and Clinical Subgroups

By

Morgan E. Meissner

Lasmiditan efficacy after a single dose was similar for the various subgroups of patients defined by baseline demographics and migraine attack characteristics.